Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

ICU TopicsInfectious Diseases

ICU · Infectious Diseases

Acute severe community-acquired pneumonia: post-influenza bacterial pneumonia

Also known as Post-influenza pneumonia · Bacterial superinfection · Staphylococcal pneumonia post-influenza

Post-influenza bacterial pneumonia is a devastating complication — influenza virus damages respiratory epithelium → secondary bacterial invasion. Most common organisms: Staphylococcus aureus (1, including MRSA and PVL-positive strains — causes necrotising pneumonia with high mortality), Streptococcus pneumoniae (2), Haemophilus influenzae. Presents as: initial viral illness (fever, myalgia, cough) → transient improvement → sudden deterioration (high fever, dyspnoea, septic shock, multilobar infiltrates, cavitation). Diagnosis: influenza PCR + sputum/blood cultures + urinary antigens. Treatment: antiviral (oseltamivir) + broad-spectrum antibiotics (cover MRSA — add vancomycin/linezolid) + supportive ICU care. Mortality: 20-40%.

low23 referencesUpdated 26 July 202613 min readVerification in progress

Practise this topic

  • 8 MCQs

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • Deterioration after initial influenza improvement = bacterial superinfection — add anti-MRSA cover
  • Post-influenza S. aureus pneumonia is often NECROTISING (cavitation on CXR) — high mortality
  • PVL-positive S. aureus: causes rapidly progressive necrotising pneumonia — often young, previously healthy
  • Always test for influenza in severe CAP during flu season — antivirals may reduce severity
On this page
Study tools

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • Deterioration after initial influenza improvement = bacterial superinfection — add anti-MRSA cover
  • Post-influenza S. aureus pneumonia is often NECROTISING (cavitation on CXR) — high mortality
  • PVL-positive S. aureus: causes rapidly progressive necrotising pneumonia — often young, previously healthy
  • Always test for influenza in severe CAP during flu season — antivirals may reduce severity
The one-line answer

Post-influenza bacterial pneumonia is the bacterial invasion that follows influenza injury to the airway. Staphylococcus aureus is the headline organism — including community-associated MRSA and PVL-positive strains that cause necrotising, cavitating, lethal pneumonia — with pneumococcus and Haemophilus influenzae close behind. The signature course is biphasic: viral illness, a deceptive improvement, then catastrophic deterioration with septic shock and multilobar infiltrates. Treat both enemies at once — oseltamivir for the virus and broad antibiotics that cover MRSA from the first hour — and mortality still runs 20 to 40 percent.[2]

Meet the patient

A 31-year-old previously well woman arrives in mid-winter with a seven-day influenza-like illness that had begun to clear. Overnight she spikes a high fever, coughs up blood-streaked sputum, and becomes breathless and cold. She is septic — MAP 58, HR 142, RR 36, SpO2 88 percent on 15 L — and the chest X-ray shows multilobar consolidation with early cavitation. Influenza A PCR is positive.[2]

This is the canonical post-influenza stem, and the question it plants is question whole topic answers: when does "getting better" become the most dangerous moment of the illness? The answer is the biphasic curve — the bacterial superinfection strikes just as the viral illness seems to be resolving, and the organism most likely to kill the patient is Staphylococcus aureus.[3]

[2]
ICU Fellowship (CICM) Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the ICU Fellowship (CICM) fellowship library.

Sign in to continueSee pricing
References23ShowHide
  1. [1]Niederman MS, Torres A Severe community-acquired pneumonia. Intensive care medicine, 2022.PMID 36517046
  2. [2]Martin-Loeches I, van Someren Gréve F, Schultz MJ Bacterial pneumonia as an influenza complication. Current opinion in infectious diseases, 2017.PMID 27984245
  3. [3]Morens DM, Taubenberger JK, Fauci AS Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. The Journal of infectious diseases, 2008.PMID 18710327
  4. [4]Rynda-Apple A, Robinson KM, Alcorn JF Influenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms of Disease. Infection and immunity, 2015.PMID 26216421
  5. [5]Sun K, Metzger DW Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nature medicine, 2008.PMID 18438414
  6. [6]Uyeki TM, Hui DS, Zambon M, et al. Influenza. Lancet (London, England), 2022.PMID 36030813
  7. [7]Uyeki TM Influenza. Annals of internal medicine, 2021.PMID 34748378
  8. [8]Harper SA, Bradley JS, Englund JA, et al. Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009.PMID 19281331
  9. [9]Engler RJM, Nelson MR Host immune responses to influenza infection and vaccines: Lessons learned for all viral pandemic challenges. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2020.PMID 32564928
  10. [10]Chow EJ, Doyle JD, Uyeki TM Influenza virus-related critical illness: prevention, diagnosis, treatment. Critical care (London, England), 2019.PMID 31189475
  11. [11]He G, Massarella J, Ward P Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802. Clinical pharmacokinetics, 1999.PMID 10628898
  12. [12]Ueda T, Takesue Y, Nakajima A Vancomycin loading dose is associated with increased early clinical response without attainment of initial target trough concentration at a steady state in patients with methicillin-resistant Staphylococcus aureus infections. Journal of clinical pharmacy and therapeutics, 2020.PMID 32301537
  13. [13]Rybak MJ, Le J, Lodise TP Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy, 2020.PMID 32227354
  14. [14]Rubinstein E, Cammarata S, Oliphant T Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001.PMID 11170948
  15. [15]Taboada M, Melnick D, Iaconis J Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials. The Journal of antimicrobial chemotherapy, 2016.PMID 26702925
  16. [16]Paterson DL Clinical experience with recently approved antibiotics. Current opinion in pharmacology, 2006.PMID 16904377
  17. [17]Gillet Y, Issartel B, Vanhems P Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet (London, England), 2002.PMID 11888586
  18. [18]Anzueto A, Niederman MS, Pearle J Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006.PMID 16323095
  19. [19]Welliver R, Monto AS, Carewicz S Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA, 2001.PMID 11176912
  20. [20]American College of Obstetricians and Gynecologists ACOG Committee Opinion No. 753: Assessment and Treatment of Pregnant Women With Suspected or Confirmed Influenza. Obstetrics and gynecology, 2018.PMID 30247362
  21. [21]Liu C, Bayer A, Cosgrove SE Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011.PMID 21208910
  22. [22]Acute Respiratory Distress Syndrome Network Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The New England journal of medicine, 2000.PMID 10793162
  23. [23]Stevens DL, Ma Y, Salmi DB Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. The Journal of infectious diseases, 2007.PMID 17191165

Test yourself

Practise what you just read

  • 8 MCQs
ICU Fellowship (CICM) Pro

$29/ monthor $279 / year

The complete ICU Fellowship (CICM) library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousAcute severe community-acquired pneumonia: pneumonia in immunocompromised non-HIV patientsInfectious DiseasesNextAcute severe community-acquired pneumonia: Pseudomonas pneumoniaInfectious Diseases